Email this page: News Release
Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn™ to Add Antimicrobial Language
To (email address):
Separate multiple addresses with commas. Maximum 200 characters.
Your email address:
These email addresses will be used to email the page on your behalf and will not be used by Sonoma Pharmaceuticals, Inc. for any marketing purposes.
Add a comment:
Link to page
Type in number:
This helps Sonoma Pharmaceuticals, Inc. prevent automated submissions.